Karolina Gente

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study.

Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study.

Journal: Vaccines

Published: December 30, 2025

Digital empowerment on hold: DiGA adoption gaps-a German national cross-sectional patient survey study.

Digital empowerment on hold: DiGA adoption gaps-a German national cross-sectional patient survey study.

Journal: Rheumatology international

Published: May 14, 2025

Update on the treatment of rheumatic immune-related adverse events under immune checkpoint inhibition

Update on the treatment of rheumatic immune-related adverse events under immune checkpoint inhibition

Journal: Zeitschrift fur Rheumatologie

Published: May 12, 2025

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

Journal: Rheumatology (Oxford, England)

Published: September 06, 2024

Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG).

Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG).

Journal: The Lancet. Oncology

Published: May 03, 2024

Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis.

Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis.

Journal: Rheumatic diseases clinics of North America

Published: April 26, 2024

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Journal: Annals of the rheumatic diseases

Published: April 16, 2024

Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Journal: Annals of the rheumatic diseases

Published: April 16, 2024

The subanalysis of Rheuma-VOR demonstrates a considerable need for rheumatological care

The subanalysis of Rheuma-VOR demonstrates a considerable need for rheumatological care

Journal: Zeitschrift fur Rheumatologie

Published: January 24, 2024

Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events.

Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events.

Journal: Journal for immunotherapy of cancer

Published: August 21, 2023

Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease.

Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease.

Journal: Annals of the rheumatic diseases

Published: August 10, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026